RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s 2025 guidance “left a lot of questions unanswered”, though the firm’s follow-up discussion with the management indicated that it is certain they can hit the guided $4.50 EPS number and grow in 2026 / 2027, regardless of what happens in China, the analyst tells investors in a research note. The stock is down 40% since Illumina reported Q4 results, and the firm is setting a “more realistic” 12-month multiple, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina’s Financial Outlook Dims Amidst China’s Import Ban and Rising Competition
- Illumina guidance cut largely as expected, says Barclays
- Illumina price target lowered to $115 from $135 at Canaccord
- Illumina Updates 2025 EPS Guidance Amid Export Challenges
- Illumina sees 2025 EPS $4.50, consensus $4.51